The Contract That Created Two Wage Tracks
In Portugal’s community-pharmacy labor market, the crucial question is not whether a collective agreement mentioned a wage minimum. It is how the agreement defined the price of experience, and how changing that price for new pharmacists allowed the sector to absorb a common revenue shock unevenly. Understanding the difference between a floor, a paycheck, and a promotion path makes the later wage statistics legible: two people can perform comparable pharmacist work while being placed on different economic tracks because they entered under different rules.
The distinction matters to both sides of the employment relationship. For a pharmacy, a sectoral agreement can set a boundary below which base pay cannot normally fall, while still leaving room to alter classifications, progression, supplements, or the terms offered to someone entering a new job. For a worker, the headline starting wage is only one part of the decision. The speed of promotion determines how quickly training and experience translate into pay, and the gap between a contractual floor and actual compensation determines how much protection the rule provides in practice.
A floor is a rule, not a paycheck
Most pharmacists in Portugal’s community pharmacies were covered by a sectoral collective-bargaining agreement. The agreement set wage floors for broad experience categories. Before the crisis-era changes, a pharmacist moved through four main floors corresponding broadly to the first, second, third, and fourth or later years on the job. The normal progression was relatively quick: workers advanced after one year in each floor, reaching the top of the ordinary sequence after about four years, apart from other responsibilities and arrangements.
A wage floor is best understood as a constraint on the employer, not a prediction of what every worker receives. Actual pay could include a “wage cushion”—the amount above the contractual floor—along with premiums and supplements. A pharmacist paid above the floor therefore had at least two distinct forms of compensation: the protected base implied by the category and the additional amount negotiated or customary at the workplace. Total pay could rise further through supplements, including payments associated with particular working conditions.
That layered structure changes how a contract transmits an industry shock. If a pharmacy’s revenue falls, the employer may not be able to cut the contractual floor for an established worker immediately. But the employer and bargaining parties may still change the category to which a worker is assigned, allow the cushion to shrink, alter promotion timing, or offer a different schedule to people hired later. The floor can remain visible in the contract while the economic value of a job changes through the layers around it.
The arrangement also explains why sectoral coverage matters. A firm-by-firm wage negotiation would expose workers to the financial position and bargaining power of their particular employer. In Portugal’s pharmacy sector, the common agreement applied broadly across firms, so changes to its categories could reach many pharmacies at once. That made the contract an industry-level transmission mechanism: the product-market shock was common, but the agreement determined which dimensions of compensation could adjust and which workers were most exposed to each change.
The worker’s experience is consequently different from the employer’s accounting problem. An employer sees a total labor cost that includes base wages, supplements, premiums, and the staffing required to keep the pharmacy operating. A worker sees a current paycheck, a likely promotion date, the stability of the employer, and the value of skills in other jobs. A lower floor can reduce the employer’s cost, but for a new pharmacist it also changes the expected return on years of experience. A small difference in the first year can become a large cumulative difference if the worker remains on each level for longer.
The 2010 agreement shows that adjustment did not begin with the later two-tier schedule. It replaced the previous set of titles with five new titles and appears to have given some pharmacies an opportunity to reshuffle workers into lower floor categories. The authors find that the new floors were slightly above the old floors on paper, yet the average real wage of workers on the older tier fell. This is a useful warning: the nominal number printed beside a category does not settle what happened to people if their category, inflation-adjusted pay, or cushion changed at the same time.
The same agreement also replaced the previous overtime system with an “hours bank.” Workers could accumulate additional hours to be used for time off, but those hours did not carry the previous overtime premium. This was not simply a change to the wage floor. It altered the compensation attached to time worked, and therefore the effective value of a job for people whose schedules included extra hours. The evidence does not require us to assume that every pharmacy used the provision in exactly the same way. It is enough to recognize that collective bargaining can adjust the bundle of pay and working-time rules rather than announce one obvious wage cut.
The result is a system with interfaces between several decisions. The bargaining agreement defines categories and minimums. The employer assigns a worker to a category and may pay a cushion or supplements. The worker supplies labor under the resulting schedule, while the sector’s financial condition affects how attractive it is for the employer to hire, retain, or replace people. None of these components is the entire wage system. A description that reports only the floor misses the cushion; a description that reports only the average paycheck misses the rule that structures future progression.
The 2012 schedule changed the career clock
The decisive change came in 2012. For pharmacists hired after June of that year, the agreement introduced a lower wage schedule with a new, substantially lower entry level. The floors on the lower tier were about 10 percent below the main tier, while the new entry floor was about 24–25 percent below the previous entry floor. The agreement also slowed promotion between categories. Before 2012, a pharmacist normally moved up after one year in a floor; after the change, the progression began at two years per level and was later extended to three and then four years in subsequent agreements.
This created a two-tier system in the economically important sense: the difference was attached to the worker’s entry point and persisted through the early career. It was not merely that a few low-performing employees were paid less. A pharmacist who entered after the cutoff could be placed on a schedule that started lower and took longer to reward experience, while a colleague hired earlier remained on the older schedule. The two workers’ pay paths diverged because of the contract governing their cohort, even if the occupation and workplace were otherwise similar.
A simple time-path example makes the mechanism clearer. Imagine two qualified pharmacists with comparable responsibilities. The first enters under the earlier schedule and reaches the next floor after a year. The second enters after the 2012 change, starts at the lower entry floor, and waits longer for each promotion. Even if both eventually move upward, the second worker spends more of the first five years at lower rates. The study estimates that a 2012 entrant paid at the floor would earn about 30 percent less over those first five years than someone who entered two years earlier. The cost is therefore not confined to day one; it is built into the calendar of advancement.
Actual pay could make the gap larger or smaller than the floor schedule alone suggests. Before the crisis, pharmacists commonly received a cushion above the floor. After 2012, many newly hired pharmacists received base wages below their contractually specified floors’ customary cushion—a departure from the earlier pattern. The difference between the lower tier’s legal or contractual minimum and the worker’s actual base wage thus became part of the story. Total compensation could also include supplements and premiums, so the floor is not a complete measure of welfare. But the fact that the study finds similar overall responses in base and total wages indicates that the tier distinction was not merely an artifact of one narrow wage definition.
The agreement gave some incumbents a choice, at least in formal terms: workers hired before 2012 could move to the lower schedule in exchange for one to three additional holidays. That option illustrates the trade-off inside the contract. A worker might value time off, while an employer might gain a lower ongoing wage cost. The existence of the option does not prove how many workers accepted it or that the exchange had the same value for everyone. It does show that the lower tier was not defined only by a one-way administrative cutoff; some established workers could trade between cash compensation and non-wage benefits.
The later agreements extended the adjustment rather than quickly restoring the old career ladder. The 2014 agreement continued the 2012 arrangement without major updates. In 2016, promotion to the next floor required four years instead of the three years specified under the preceding schedule, and performance bonuses were introduced for lower-tier workers. Those bonuses were linked to annual sales to the national health service and paid in the first quarter of the following year, but the worker survey did not observe their size because the payment timing did not align with the survey period. The 2018 agreement made small floor increases without removing the two-tier architecture. In 2024, the entry floor rose more than the general schedule, but promotion on the lower tier was slowed further. These later details matter less as a catalogue than as evidence that the wage-track distinction persisted and evolved rather than disappearing after one contract.
The system can be represented as a set of pay states and transitions:
This diagram describes a contractual lifecycle, not a claim that every pharmacist passes through each state in exactly the same way. The main tier is the earlier path; the lower-tier entry state is the new starting point; slower promotions determine how long the worker remains at each level. The incumbent transition is optional in the evidence, and the later bonus is not fully measured. Keeping those qualifications visible is essential because a clean diagram can otherwise make a heterogeneous workplace look mechanically uniform.
Why would bargaining parties choose such an arrangement during a sector-wide loss of value? The contract offered a way to reduce labor costs without requiring an identical immediate cut for every established worker. It could preserve a hiring channel for a sector that still needed pharmacists, protect some existing nominal arrangements, and distribute the adjustment over future cohorts. But the same design shifted risk toward people with less tenure and less bargaining power. New entrants had fewer accumulated rights inside the occupation and were deciding whether to accept the available job, search for alternatives, or leave the field altogether. The contract’s short-run stabilizing function and its distributional cost are therefore part of the same mechanism.
There are limits to what can be inferred from the contract alone. The wage floors were extracted from collective agreements and matched to worker records, but the source does not establish that every employer applied each provision identically. The study also cannot fully measure the performance bonuses introduced in 2016. Nor does a lower contractual floor prove that the employer captured the entire difference as profit; the sector’s revenue, staffing, and other costs were changing at the same time. The agreement identifies a credible route for cohort-specific adjustment, not a complete accounting of every euro.
What it does establish is the institutional possibility that the earlier chapter’s common margin shock lacked on its own. The prescription market reduced the value available to pharmacies, but the agreement supplied a schedule through which that reduction could reach labor. The schedule did not need to cut every incumbent’s wage by the same percentage. It could lower entry pay, stretch the time to promotion, alter cushions, and let the lower-paid group grow as new workers arrived. The next question is how much that design changed the observed average wage—and whether the aggregate decline mainly reflects smaller paychecks for existing pharmacists or the expanding weight of workers hired under the new track.